BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10673855)

  • 1. [Competitive polymerase chain reaction: a new method for measuring N-myc amplification].
    Tornóczky T; Vass J; Kajtár P; Kardos M; Lendvai G; Varga T; Pajor L
    Orv Hetil; 2000 Jan; 141(1):27-30. PubMed ID: 10673855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
    Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
    Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
    Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
    Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
    Sartelet H; Grossi L; Pasquier D; Combaret V; Bouvier R; Ranchère D; Plantaz D; Munzer M; Philip T; Birembaut P; Zahm JM; Bergeron C; Gaillard D; Pasquier B
    J Pathol; 2002 Sep; 198(1):83-91. PubMed ID: 12210067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
    Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
    Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluorescent in situ hybridization (FISH) and the polymerase chain reaction (PCR) for detection of residual neuroblastoma cells.
    Eckschlager T; McClain K
    Neoplasma; 1996; 43(5):301-3. PubMed ID: 8996548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
    Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
    Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction.
    Norris MD; Haber M; Gilbert J; Kavallaris M; Marshall GM; Stewart BW
    Prog Clin Biol Res; 1994; 385():27-33. PubMed ID: 7972220
    [No Abstract]   [Full Text] [Related]  

  • 10. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
    Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
    Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
    Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
    Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma.
    Gallego S; Reventos J; Sanchez de Toledo J; Munell F
    Anticancer Res; 1998; 18(2A):1211-5. PubMed ID: 9615790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method.
    Noguchi M; Hirohashi S; Tsuda H; Nakajima T; Hara F; Shimosato Y
    Mod Pathol; 1988 Nov; 1(6):428-32. PubMed ID: 3222254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
    Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc amplification was rarely detected by fluorescence in situ hybridization in retinoblastoma.
    Kim JH; Choi JM; Yu YS; Kim DH; Kim JH; Kim KW
    Hum Pathol; 2008 Aug; 39(8):1172-5. PubMed ID: 18538370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of Nmyc amplification and deletion of the short arm of chromosome 1 in neuroblastoma tumours: a single institution study.
    Michon J; Delattre O; Zucker JM; Peter M; Delonlay P; Luciani S; Mosseri V; Vielh P; Neuenschwander S; Thomas G
    Prog Clin Biol Res; 1994; 385():11-7. PubMed ID: 7972201
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
    Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
    Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
    Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.